NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market on Monday that its second quarter revenues rose 3 percent year over year, thanks almost entirely to a 4 percent increase in ita clinical laboratory service revenues.

For the three months ended Jan. 31, the firm reported total revenues of $27.0 million, up from $26.3 million in Q2 2017.